These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2156001

  • 1. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
    Shimeld C, Hill TJ, Blyth WA, Easty DL.
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
    [Abstract] [Full Text] [Related]

  • 2. An improved model of recurrent herpetic eye disease in mice.
    Shimeld C, Hill T, Blyth B, Easty D.
    Curr Eye Res; 1989 Nov; 8(11):1193-205. PubMed ID: 2558849
    [Abstract] [Full Text] [Related]

  • 3. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA, Knipe DM.
    Virology; 1997 Dec 22; 239(2):315-26. PubMed ID: 9434723
    [Abstract] [Full Text] [Related]

  • 4. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
    Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL.
    J Gen Virol; 1982 Nov 22; 63 (Pt 1)():95-101. PubMed ID: 6294236
    [Abstract] [Full Text] [Related]

  • 5. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK, Foster CS, Wells PA, Knipe D, Caron L, Greene MI.
    Clin Immunol Immunopathol; 1986 Aug 22; 40(2):326-34. PubMed ID: 3013476
    [Abstract] [Full Text] [Related]

  • 6. Non-traumatic acquisition of herpes simplex virus infection through the eye.
    Kaye SB, Shimeld C, Grinfeld E, Maitland NJ, Hill TJ, Easty DL.
    Br J Ophthalmol; 1992 Jul 22; 76(7):412-8. PubMed ID: 1320925
    [Abstract] [Full Text] [Related]

  • 7. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
    Hendricks RL, Weber PC, Taylor JL, Koumbis A, Tumpey TM, Glorioso JC.
    J Gen Virol; 1991 Jul 22; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
    [Abstract] [Full Text] [Related]

  • 8. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice.
    Shimeld C, Hill TJ, Blyth WA, Easty DL.
    J Gen Virol; 1990 Feb 22; 71 ( Pt 2)():397-404. PubMed ID: 2155293
    [Abstract] [Full Text] [Related]

  • 9. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS, Sandstrom IK, Wells PA, Thompson P, Daigle J, Opremcak EM.
    Curr Eye Res; 1988 Nov 22; 7(11):1051-61. PubMed ID: 2854037
    [Abstract] [Full Text] [Related]

  • 10. Spread of herpes simplex virus within ocular nerves of the mouse: demonstration of viral antigen in whole mounts of eye tissue.
    Dyson H, Shimeld C, Hill TJ, Blyth WA, Easty DL.
    J Gen Virol; 1987 Dec 22; 68 ( Pt 12)():2989-95. PubMed ID: 2826644
    [Abstract] [Full Text] [Related]

  • 11. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
    McLeish W, Rubsamen P, Atherton SS, Streilein JW.
    Reg Immunol; 1989 Dec 22; 2(4):236-43. PubMed ID: 2561960
    [Abstract] [Full Text] [Related]

  • 12. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul 22; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

  • 13. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
    Oakes JE, Rector JT, Lausch RN.
    Invest Ophthalmol Vis Sci; 1984 Feb 22; 25(2):188-94. PubMed ID: 6321384
    [Abstract] [Full Text] [Related]

  • 14. Spread of HSV and establishment of latency after corneal infection in inbred mice.
    Abghari SZ, Stulting RD, Nigida SM, Downer DN, Nahmias AJ.
    Invest Ophthalmol Vis Sci; 1986 Jan 22; 27(1):77-82. PubMed ID: 3000975
    [Abstract] [Full Text] [Related]

  • 15. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
    Cook SD, Paveloff MJ, Doucet JJ, Cottingham AJ, Sedarati F, Hill JM.
    Invest Ophthalmol Vis Sci; 1991 Apr 22; 32(5):1558-61. PubMed ID: 1849874
    [Abstract] [Full Text] [Related]

  • 16. Recovery of herpes simplex virus from the corneas of experimentally infected rabbits.
    Cook SD, Batra SK, Brown SM.
    J Gen Virol; 1987 Jul 22; 68 ( Pt 7)():2013-7. PubMed ID: 3037020
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
    Thompson P, Wells PA, Sandstrom IK, Opremcak EM, Millin JA, Daigle JA, Foster CS.
    Curr Eye Res; 1988 Nov 22; 7(11):1043-9. PubMed ID: 2854036
    [Abstract] [Full Text] [Related]

  • 18. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
    Green MT, Dunkel EC, Pavan-Langston D.
    Exp Eye Res; 1987 Sep 22; 45(3):375-83. PubMed ID: 2822456
    [Abstract] [Full Text] [Related]

  • 19. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP, Veress LA, Gebhardt BM, Carr DJ.
    Virology; 1997 Sep 29; 236(2):328-37. PubMed ID: 9325240
    [Abstract] [Full Text] [Related]

  • 20. Ocular herpes simplex and the establishment of latent infection.
    Tullo AB, Easty DL, Hill TJ, Blyth WA.
    Trans Ophthalmol Soc U K (1962); 1982 Apr 29; 102 (Pt 1)():15-8. PubMed ID: 6301114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.